Kevin Deboyace

Kevin Deboyace

Pfizer Inc. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4543218
-
person_outline Kevin Deboyace's MOST POPULAR ARTICLES
1-) The application of modeling and prediction to the formation and stability of amorphous solid dispersionsK DeBoyace, PLD WildfongJournal of Pharmaceutical Sciences 107 (1), 57-74, 2018802018
2-) Tunable thermoassociation of binary guanosine gelsY Yu, D Nakamura, K DeBoyace, AW Neisius, LB McGownThe Journal of Physical Chemistry B 112 (4), 1130-1134, 2008802008
3-) Modeling and prediction of drug dispersability in polyvinylpyrrolidone-vinyl acetate copolymer using a molecular descriptorK DeBoyace, IS Buckner, Y Gong, TR Ju, PLD WildfongJournal of Pharmaceutical Sciences 107 (1), 334-343, 2018152018
4-) Raman spectroscopy for the process analysis of the manufacturing of a suspension metered dose inhalerJ Butz, L de la Cruz, J DiTonno, K DeBoyace, G Ewing, B Donovan, ...Journal of pharmaceutical and biomedical analysis 54 (5), 1013-1019, 2011152011
5-) Predicting density of amorphous solid materials using molecular dynamics simulationM Bookwala, K DeBoyace, IS Buckner, PLD WildfongAAPS PharmSciTech 21, 1-11, 2020122020